Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
32,610,815
-
Shares change
-
+1,137,707
-
Total reported value, excl. options
-
$1,570,066,541
-
Value change
-
+$38,237,714
-
Put/Call ratio
-
131%
-
Number of buys
-
114
-
Number of sells
-
-63
-
Price
-
$48.13
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q2 2015
212 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q2 2015.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32,610,815 shares
of 80,437,135 outstanding shares and own 40.54% of the company stock.
Largest 10 shareholders include FMR LLC (2,673,563 shares), WESTFIELD CAPITAL MANAGEMENT CO LP (2,466,760 shares), WELLINGTON MANAGEMENT GROUP LLP (2,198,606 shares), VANGUARD GROUP INC (1,720,391 shares), WELLS FARGO & COMPANY/MN (1,593,360 shares), WADDELL & REED FINANCIAL INC (1,271,500 shares), BB BIOTECH AG (1,252,912 shares), BlackRock Fund Advisors (1,251,897 shares), PUTNAM INVESTMENTS LLC (1,187,264 shares), and BROOKSIDE CAPITAL MANAGEMENT LLC (1,038,355 shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.